protein kinase inhibitors (Carna/Janssen Biotech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotein kinase inhibitors (Carna/Janssen Biotech)
Drug Alias Nameprotein kinase inhibitors (Carna/Kaken)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Biotech IncCarna Biosciences IncKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A